Profile data is unavailable for this security.
About the company
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
- Revenue in SEK (TTM)630.39m
- Net income in SEK10.88m
- Incorporated1991
- Employees157.00
- LocationProbi ABIdeongatan 1ALUND 223 70SwedenSWE
- Phone+46 462868920
- Fax+46 462868928
- Websitehttps://probi.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Moberg Pharma AB (publ) | 8.78m | -18.25m | 872.85m | 9.00 | -- | 0.9166 | -- | 99.37 | -0.6245 | -0.6245 | 0.2649 | 19.89 | 0.0111 | -- | 2.00 | -- | -2.30 | -- | -2.35 | -- | 73.46 | -- | -207.75 | -- | 22.03 | -- | 0.0039 | -- | -100.00 | -- | -34.26 | -- | -- | -- |
| Vistin Pharma ASA | 422.30m | 61.18m | 1.10bn | 77.00 | 17.99 | 3.55 | 13.75 | 2.61 | 1.38 | 1.38 | 9.55 | 7.01 | 1.09 | 1.89 | 7.27 | 5,501,130.00 | 15.85 | 1.73 | 19.26 | 2.11 | 64.84 | 58.92 | 14.49 | 2.36 | 1.06 | 21.05 | 0.0178 | 286.16 | 51.35 | 16.95 | 1,066.84 | -- | -0.1922 | -- |
| Photocure ASA | 524.66m | 14.12m | 1.34bn | 102.00 | 96.13 | 2.69 | 31.16 | 2.55 | 0.5155 | 0.5155 | 19.44 | 18.44 | 0.738 | 0.8767 | 9.05 | 5,159,343.00 | 1.99 | -3.06 | 2.23 | -3.54 | 94.47 | 93.64 | 2.69 | -5.15 | 4.73 | -- | 0.00 | -- | 27.35 | 22.50 | 101.36 | -- | 49.83 | -- |
| Flerie AB | 100.00k | -269.52m | 3.51bn | 2.00 | -- | 0.8243 | -- | 35,129.88 | -22.07 | -22.07 | 0.0019 | 54.59 | 0.00004 | -- | -- | 14,285.71 | -11.53 | -37.64 | -11.69 | -41.14 | -92,017.00 | -450.51 | -269,618.00 | -454.62 | -- | -2.58 | 0.0002 | -- | -- | 277.02 | 5.05 | -- | -- | -- |
| Probi AB | 630.39m | 10.88m | 4.00bn | 157.00 | 367.45 | 2.92 | 35.68 | 6.34 | 0.9552 | 0.9552 | 55.33 | 120.07 | 0.4049 | 3.24 | 7.14 | 3,939,931.00 | 0.6991 | 4.64 | 0.7409 | 4.98 | 33.18 | 42.04 | 1.73 | 9.83 | 4.83 | -- | 0.0561 | 21.42 | 1.52 | 0.7684 | -58.60 | -26.09 | 31.01 | -- |
| Swedencare AB (publ) | 2.47bn | 76.20m | 7.14bn | 559.00 | 93.61 | 0.9287 | 18.27 | 2.89 | 0.4801 | 0.4801 | 15.58 | 48.39 | 0.2428 | 2.26 | 8.69 | 5,087,037.00 | 0.7483 | 1.38 | 0.7727 | 1.43 | 56.76 | 55.34 | 3.08 | 5.10 | 1.67 | 2.42 | 0.1726 | 45.33 | 27.48 | 88.16 | -37.96 | 20.24 | 30.90 | -- |
| BioGaia AB | 1.36bn | 336.82m | 10.14bn | 222.00 | 31.19 | 6.50 | 24.84 | 7.48 | 3.33 | 3.33 | 13.42 | 16.01 | 0.6442 | -- | -- | 6,455,538.00 | 16.00 | 15.47 | 17.73 | 16.93 | 73.59 | 73.30 | 24.85 | 27.70 | -- | -- | 0.00 | 104.42 | 17.44 | 11.81 | -2.25 | 11.20 | 29.27 | 28.10 |
Data as of Nov 21 2024. Currency figures normalised to Probi AB's reporting currency: Swedish Krona SEK
13.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 30 Jun 2024 | 1.06m | 9.28% |
| SEB Investment Management AB (Denmark)as of 28 Feb 2022 | 97.02k | 0.85% |
| Deka Investment GmbHas of 30 Jun 2024 | 85.19k | 0.75% |
| Handelsbanken Fonder ABas of 31 Oct 2024 | 71.00k | 0.62% |
| Nordea Investment Management AB (Finland)as of 31 Aug 2023 | 67.24k | 0.59% |
| SEB Investment Management ABas of 31 Oct 2024 | 59.10k | 0.52% |
| FCG Fonder ABas of 31 Oct 2024 | 38.76k | 0.34% |
| Skandia Investment Management ABas of 30 Sep 2024 | 18.29k | 0.16% |
| MFS International (UK) Ltd.as of 30 Sep 2024 | 16.25k | 0.14% |
| Storebrand Asset Management ASas of 30 Sep 2024 | 3.86k | 0.03% |
More ▼
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
